Indian Cyclophosphamide Exporters: Complete Supplier Ranking with Market Share — 518 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cyclophosphamide buyer importing from India?

CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) is the largest cyclophosphamide importer from India with a 42.5% market share and import value of $8.3M.

Q: How many cyclophosphamide buyers import from India?

There are 518 active cyclophosphamide buyers importing from India, with a combined import market of $19.5M across 2,113 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cyclophosphamide buyers from India?

The top 5 cyclophosphamide buyers — CIPLA USA INC UPS SUPPLY CHAIN SOLU, EUGIA US LLC, EUGIA US LLC,, J. KNIPPER & COMPANY, COMMERCIAL BANK — together control 74.5% of total cyclophosphamide import value from India.

Suresh Sormare

Cyclophosphamide

India Pharmaceutical Trade Intelligence

$19.5M259 Suppliers114 CountriesHS 30049041

ExportsIndia → UNITED STATES83.8%India → ETHIOPIA2.3%

ImportsUNITED STATES → India$592.7K CANADA → India$11.9K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $16.3M through 61 shipments. This represents a market share of 83.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $8.3M (50.7% of country's total business)

• EUGIA US LLC - $3.4M (21.1% of country's total business)

• EUGIA US LLC, - $1.9M (11.5% of country's total business)

• J. KNIPPER & COMPANY - $467.5K (2.9% of country's total business)

• AUROMEDICS PHARMA, LLC,., - $375.5K (2.3% of country's total business)

• Rest of United States's importers - $1.9M (11.5% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $267.2K, indicating premium pricing strategy compared to the market average of $9.2K.

United States is a key market for Cyclophosphamide imports, representing 83.8% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Cyclophosphamide buyer market intelligence

1Buyer Segment Analysis

The importers of Cyclophosphamide from India can be categorized into several key segments:

1. Distributors: Entities such as CIPLA USA INC UPS SUPPLY CHAIN SOLU and EUGIA US LLC fall into this category. These distributors procure large quantities of Cyclophosphamide to supply to various healthcare providers, including hospitals and pharmacies. Their purchasing behavior is characterized by bulk orders and a high repeat buyer rate, reflecting ongoing demand and established supply chains.

2. Government Procurement Agencies: Organizations like the Commercial Bank in Ethiopia represent government procurement bodies. They typically engage in tender-based purchasing, aligning with national healthcare programs and policies. Their order patterns are often large-scale and periodic, corresponding with budget cycles and public health initiatives.

3. Hospital Groups and Healthcare Providers: Entities such as J. KNIPPER & COMPANY and AUROMEDICS PHARMA, LLC are indicative of this segment. These buyers procure Cyclophosphamide directly for patient treatment within their facilities. Their purchasing behavior includes regular orders to maintain adequate stock levels, ensuring uninterrupted patient care.

4. Re-exporters: Companies like AMBICA INTERNATIONAL CORPORATION in the Philippines may act as re-exporters, importing Cyclophosphamide for distribution to neighboring regions. Their order patterns can be irregular, influenced by market demand and regional distribution agreements.

5. Contract Manufacturers: Entities such as HIRAD PHARMED UNIT in Iran may function as contract manufacturers, importing Cyclophosphamide as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is typically aligned with production schedules and contractual obligations.

Country-Specific Import Regulations

TransData Nexus Cyclophosphamide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Cyclophosphamide are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Cyclophosphamide is approved by the FDA. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic products.

Estimated Timeline for Registration: The approval process can range from 10 months to several years, depending on the complexity of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049041 are generally duty-free in the United States.

2. Ethiopia:

Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).

Demand Drivers & Market Opportunity

TransData Nexus Cyclophosphamide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cyclophosphamide in importing countries is driven by several factors:

1. Disease Prevalence: Cyclophosphamide is primarily used in the treatment of various cancers and autoimmune diseases. The prevalence of these conditions necessitates a consistent supply of this medication.

2. Government Healthcare Programs: Many countries have national health programs that prioritize the treatment of chronic and life-threatening diseases, leading to increased procurement of essential medicines like Cyclophosphamide.

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage have resulted in greater access to essential medicines, thereby increasing demand.

4. WHO Essential Medicines List Procurement: Cyclophosphamide's inclusion in the WHO Essential Medicines List underscores its importance, prompting countries to ensure its availability through public procurement systems.

5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender-based systems to procure medicines, ensuring cost-effectiveness and consistent supply.

Our data indicates that between 2022 and 2026, 518 buyers across 114 countries imported Cyclophosphamide from India, reflecting a broad and sustained global demand for this essential medication.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Cyclophosphamide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest cyclophosphamide buyer importing from India?

Based on import volume and value, CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) leads with $8.3M in imports and a 42.5% market share — the highest of any single cyclophosphamide importer. EUGIA US LLC (UNITED STATES) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.

QHow many companies buy cyclophosphamide from India?

There are 518 active cyclophosphamide buyers importing from India, with a combined market of $19.5M across 2,113 shipments to 114 countries. The top 5 buyers hold 74.5% of total import value, while the remaining 513 buyers handle the other 25.5%.

QWhich countries import the most cyclophosphamide from India?

The top importing countries for cyclophosphamide from India are United States (83.8%), Ethiopia (2.3%), Peru (1.4%), Philippines (1.4%), Mexico (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of cyclophosphamide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for cyclophosphamide from India?

The average import transaction value for cyclophosphamide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Cyclophosphamide buyer market intelligence

1Buyer Segment Analysis

The importers of Cyclophosphamide from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Cyclophosphamide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Cyclophosphamide are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The approval process can range from 10 months to several years, depending on the complexity of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049041 are generally duty-free in the United States.

2. Ethiopia:

Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).

Demand Drivers & Market Opportunity

TransData Nexus Cyclophosphamide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cyclophosphamide in importing countries is driven by several factors:

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage have resulted in greater access to essential medicines, thereby increasing demand.

5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender-based systems to procure medicines, ensuring cost-effectiveness and consistent supply.

Our data indicates that between 2022 and 2026, 518 buyers across 114 countries imported Cyclophosphamide from India, reflecting a broad and sustained global demand for this essential medication.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cyclophosphamide

Cyclophosphamide

Who Buys Cyclophosphamide from India — 518 Importers Behind a $19.5M Market

Top Cyclophosphamide Importers — Ranked by Import Value

Top Cyclophosphamide Buyers & Importers

Related Analysis

Need Details?

Cyclophosphamide — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Cyclophosphamide — and from which countries?

Cyclophosphamide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Cyclophosphamide Buyers & Importers

QWho is the largest cyclophosphamide buyer importing from India?

QHow many companies buy cyclophosphamide from India?

QWhich countries import the most cyclophosphamide from India?

QWhat is the average import order value for cyclophosphamide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Ethiopia

3Peru

4Philippines

5Mexico

Analysis Methodology